Notice Information
Notice Title
Lung Cancer Screening - DAP C
Notice Description
The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget.
Lot Information
Lot 1
The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget. The new contract will commence 1st September 2026 and conclude on 31st March 2028. The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 30%. Value 20%. Integration, Collaboration & Service Sustainability 25%, Access Health Inequalities and Choice 20%; Social Value 5%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. The considerable change test has been completed and the unit price has not changed and the activity growth is within typical patient growth.
Procurement Information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: Kevin.Edwards@Attain.co.uk The Decision Maker for this award was the ICB Executive Board. There were no conflicts of interest declared by individuals making the decision. All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2. The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-06d7c8
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/072248-2026
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
-
- CPV Codes
85100000 - Health services
85121000 - Medical practice services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,096,896 £1M-£10M
Notice Dates
- Publication Date
- 30 Jul 20266 days ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 27 Apr 20263 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ESSEX INTEGRATED CARE BOARD
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- CHELMSFORD
- Postcode
- CM1 1QH
- Post Town
- Chelmsford
- Country
- England
-
- Major Region (ITL 1)
- TLH East (England)
- Basic Region (ITL 2)
- TLH3 Essex
- Small Region (ITL 3)
- TLH36 Heart of Essex
- Delivery Location
- TLH3 Essex
-
- Local Authority
- Chelmsford
- Electoral Ward
- Moulsham and Central
- Westminster Constituency
- Chelmsford
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-06d7c8-2026-07-30T14:36:20+01:00",
"date": "2026-07-30T14:36:20+01:00",
"ocid": "ocds-h6vhtk-06d7c8",
"description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: Kevin.Edwards@Attain.co.uk The Decision Maker for this award was the ICB Executive Board. There were no conflicts of interest declared by individuals making the decision. All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2. The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.",
"initiationType": "tender",
"tender": {
"id": "ACE-0030-2026-ESX",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Lung Cancer Screening - DAP C",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85121000",
"description": "Medical practice services"
},
"mainProcurementCategory": "services",
"description": "The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget.",
"lots": [
{
"id": "1",
"description": "The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget. The new contract will commence 1st September 2026 and conclude on 31st March 2028. The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 30%. Value 20%. Integration, Collaboration & Service Sustainability 25%, Access Health Inequalities and Choice 20%; Social Value 5%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. The considerable change test has been completed and the unit price has not changed and the activity growth is within typical patient growth.",
"awardCriteria": {
"criteria": [
{
"name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "100"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
{
"scheme": "CPV",
"id": "85121000",
"description": "Medical practice services"
}
],
"deliveryAddresses": [
{
"region": "UKH3"
}
],
"deliveryLocation": {
"description": "Essex"
},
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: Kevin.Edwards@Attain.co.uk The Decision Maker for this award was the ICB Executive Board. There were no conflicts of interest declared by individuals making the decision. All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2. The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard."
},
"awards": [
{
"id": "072248-2026-1",
"relatedLots": [
"1"
],
"title": "Lung Cancer Screening",
"status": "active",
"suppliers": [
{
"id": "GB-COH-13759045",
"name": "GP Primary Choice Ltd"
}
]
}
],
"parties": [
{
"id": "GB-NHS-D7T5G",
"name": "NHS Essex Integrated Care Board",
"identifier": {
"legalName": "NHS Essex Integrated Care Board",
"id": "D7T5G",
"scheme": "GB-NHS"
},
"address": {
"streetAddress": "Seax House, Victoria Road South",
"locality": "Chelmsford",
"region": "UKH3",
"postalCode": "CM1 1QH",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Kevin Edwards",
"telephone": "+44 1268594350",
"email": "kevin.edwards@attain.co.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.essex.icb.nhs",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
}
},
{
"id": "GB-COH-13759045",
"name": "GP Primary Choice Ltd",
"identifier": {
"legalName": "GP Primary Choice Ltd",
"id": "13759045",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Ground Floor, Block A University of Essex Knowledge Gateway Parkside Office Village Nesfield Road",
"locality": "Colchester",
"region": "UKH3",
"postalCode": "CO4 3ZL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-182665",
"name": "The Independent Patient Choice and Procurement Panel",
"identifier": {
"legalName": "The Independent Patient Choice and Procurement Panel"
},
"address": {
"streetAddress": "NHS England, 7 and 8 Wellington Place",
"locality": "Leeds",
"postalCode": "LS1 4AP",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "england.choice@nhs.net"
},
"roles": [
"reviewBody"
],
"details": {
"url": "http://www.england.nhs.uk"
}
},
{
"id": "GB-FTS-179607",
"name": "NHS Essex Integrated Care Board",
"identifier": {
"legalName": "NHS Essex Integrated Care Board"
},
"address": {
"streetAddress": "Seax House, Victoria Road South",
"locality": "Chelmsford",
"postalCode": "CM1 1QH",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 1268594350",
"email": "kevin.edwards@attain.co.uk"
},
"roles": [
"mediationBody"
]
}
],
"buyer": {
"id": "GB-NHS-D7T5G",
"name": "NHS Essex Integrated Care Board"
},
"contracts": [
{
"id": "072248-2026-1",
"awardID": "072248-2026-1",
"title": "Lung Cancer Screening",
"status": "active",
"value": {
"amount": 1096896,
"currency": "GBP"
},
"dateSigned": "2026-04-28T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 1
},
{
"id": "3",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 1
},
{
"id": "4",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 1
},
{
"id": "5",
"measure": "electronicBids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}